MPM Capital Expands, Renews Early Stage Focus in Biotech

MPM Capital has been around since 1997 and to date has raised nearly $4.0 billion in capital. The firm is particularly skilled in life sciences and can invest across private and public companies. Recently, it announced the closing of its seventh venture fund, BioVentures 2018, with total committed capital of $400 million...